Role of versican V0/V1 and CD44 in the regulation of human melanoma cell behavior

International Journal of Molecular Medicine

Volumn 27, Issue 2, 2011, Pages 269-275

  Hernández, Daniel ^a   Miquel Serra, Laia ^a   Docampo, Maria José ^a   Marco Ramell, Anna ^a   Bassols, Anna ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Adhesion; CD44; Hyaluronan; Melanoma; Migration; Proliferation; Versican

Indexed keywords

CD44V ANTIGEN; COLLAGEN TYPE 1; FIBRONECTIN; FLUORESCEIN ISOTHIOCYANATE; HYALURONIC ACID; LAMININ; VERSICAN; VITRONECTIN;

ARTICLE; CANCER CELL CULTURE; CELL ADHESION; CELL FUNCTION; CELL MIGRATION; CELL PROLIFERATION; CELL SURFACE; CONTROLLED STUDY; CYTOPLASM; GENE SILENCING; HUMAN; HUMAN CELL; INTERNALIZATION; MELANOMA CELL; PRIORITY JOURNAL; PROTEIN BINDING; WOUND HEALING;

ANTIGENS, CD44; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; GENE SILENCING; HUMANS; MELANOMA; PROTEIN ISOFORMS; VERSICANS;

EID: 78751653255     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2010.577     Document Type: Article

References (46)

1. Hsu MY, Meier F and Herlyn M: Melanoma development and progression: A conspiracy between tumor and host. Differentiation 70: 522-536, 2002.
2. Lee JT and Herlyn M: Microenvironmental influences in melanoma progression. J Cell Biochem 101: 862-872, 2007.
3. Touab M, Villena J, Barranco C, et al: Versican is differentially expressed in human melanoma and may play a role in tumor development. Am J Pathol 160: 549-557, 2002.
4. Docampo MJ, Rabanal RM, Miquel-Serra L, et al: Altered expression of versican and hyaluronan in melanocytic tumors of dogs. Am J Vet Res 68: 1376-1385, 2007.
5. Touab M, Arumi-Uria M, Barranco C and Bassols A: Expression of the proteoglycans versican and mel-CSPG in dysplastic nevi. Am J Clin Pathol 119: 587-593, 2003. (Pubitemid 37046410)
6. Wight TN: Versican: A versatile extracellular matrix proteoglycan in cell biology. Curr Opin Cell Biol 14: 617-623, 2002.
7. Ang LC, Zhang Y, Cao L, et al: Versican enhances locomotion of astrocytoma cells and reduces cell adhesion through its G1 domain. J Neuropathol Exp Neurol 58: 597-605, 1999.
8. Dutt S, Kleber M, Matasci M, et al: Versican V0 and V1 guide migratory neural crest cells. J Biol Chem 281: 12123-12131, 2006.
9. Huang R, Merrilees MJ, Braun K, et al: Inhibition of versican synthesis by antisense alters smooth muscle cell phenotype and induces elastic fiber formation in vitro and in neointima after vessel injury. Circ Res 98: 370-377, 2006.
10. Arslan F, Bosserhoff AF, Nickl-Jockschat T, et al: The role of versican isoforms V0/V1 in glioma migration mediated by transforming growth factor-beta2. Br J Cancer 96: 1560-1568, 2007.
11. Kodama J, Hasengaowa K, Kusumoto T, et al: Prognostic significance of stromal versican expression in human endometrial cancer. Ann Oncol 18: 269-274, 2007. (Pubitemid 46323092)
12. Koyama H, Hibi T, Isogai Z, et al: Hyperproduction of hyaluronan in neu-induced mammary tumor accelerates angiogenesis through stromal cell recruitment: possible involvement of versican/PG-M. Am J Pathol 170: 1086-1099, 2007.
13. Ricciardelli C, Russell DL, Ween MP, et al:. Formation of hyaluronan- and versican-rich pericellular matrix by prostate cancer cells promotes cell motility. J Biol Chem 282: 10814-10825, 2007. (Pubitemid 47093429)
14. Yang BL, Yang BB, Erwin M, et al: Versican G3 domain enhances cellular adhesion and proliferation of bovine intervertebral disc cells cultured in vitro. Life Sci 73: 3399-3413, 2003.
15. Wu Y, Zhang Y, Cao L, et al: Identification of the motif in versican G3 domain that plays a dominant-negative effect on astrocytoma cell proliferation through inhibiting versican secretion and binding. J Biol Chem 276: 14178-14186, 2001.
16. Cattaruzza S, Schiappacassi M, Kimata K, et al: The globular domains of PG-M/versican modulate the proliferation-apoptosis equilibrium and invasive capabilities of tumor cells. FASEB J 18: 779-781, 2004.
17. Wu Y, Chen L, Cao L, et al: Overexpression of the C-terminal PG-M/versican domain impairs growth of tumor cells by intervening in the interaction between epidermal growth factor receptor and beta1-integrin. J Cell Sci 117: 2227-2237, 2004.
18. Yee AJ, Akens M, Yang BL, et al: The effect of versican G3 domain on local breast cancer invasiveness and bony metastasis. Breast Cancer Res 9: R47, 2007.
19. Yamagata M and Kimata K: Repression of a malignant cell-substratum adhesion phenotype by inhibiting the production of the anti-adhesive proteoglycan, PG-M/versican. J Cell Sci 107: 2581-2590, 1994.
20. Sakko AJ, Ricciardelli C, Mayne K, et al: Modulation of prostate cancer cell attachment to matrix by versican. Cancer Res 63: 4786-4791, 2003.
21. Isacke CM and Yarwood H: The hyaluronan receptor, CD44. Int J Biochem Cell Biol 34: 718-721, 2002.
22. Marhaba R and Zoller M: CD44 in cancer progression: adhesion, migration and growth regulation. J Mol Histol 35: 211-231, 2004.
23. Ahrens T, Assmann V, Fieber C, et al: CD44 is the principal mediator of hyaluronic-acid-induced melanoma cell proliferation. J Invest Dermatol 116: 93-101, 2001.
24. Marhaba R, Bourouba M and Zoller M: CD44v6 promotes proliferation by persisting activation of MAP kinases. Cell Signal 17: 961-973, 2005.
25. Takano H, Nakazawa S, Shirata N, et al: Involvement of CD44 in mast cell proliferation during terminal differentiation. Lab Invest 89: 446-455, 2009.
26. Bourguignon LY, Gilad E and Peyrollier K: Heregulin-mediated ErbB2-ERK signaling activates hyaluronan synthases leading to CD44-dependent ovarian tumor cell growth and migration. J Biol Chem 282: 19426-19441, 2007.
27. Li CZ, Liu B, Wen ZQ, et al: Inhibition of CD44 expression by small interfering RNA to suppress the growth and metastasis of ovarian cancer cells in vitro and in vivo. Folia Biol (Praha) 54: 180-186, 2008.
28. Afify A, Purnell P and Nguyen L: Role of CD44s and CD44v6 on human breast cancer cell adhesion, migration, and invasion. Exp Mol Pathol 86: 95-100, 2009.
29. Knudson W, Chow G and Knudson CB: CD44-mediated uptake and degradation of hyaluronan. Matrix Biol 21: 15-23, 2002.
30. Harada H and Takahashi M: CD44-dependent intracellular and extracellular catabolism of hyaluronic acid by hyaluronidase-1 and -2. J Biol Chem 282: 5597-5607, 2007.
31. Houghton AN, Eisinger M, Albino AP, et al: Surface antigens of melanocytes and melanomas. Markers of melanocyte differentiation and melanoma subsets. J Exp Med 156: 1755-1766, 1982.
32. Domenzain-Reyna C, Hernandez D, Miquel-Serra L, et al: Structure and regulation of the versican promoter: the versican promoter is regulated by AP-1 and TCF transcription factors in invasive human melanoma cells. J Biol Chem 284: 12306-12317, 2009.
33. Tzircotis G, Thorne RF and Isacke CM: Chemotaxis towards hyaluronan is dependent on CD44 expression and modulated by cell type variation in CD44-hyaluronan binding. J Cell Sci 118: 5119-5128, 2005.
34. Embry JJ and Knudson W: G1 domain of aggrecan cointernalizes with hyaluronan via a CD44-mediated mechanism in bovine articular chondrocytes. Arthritis Rheum 48: 3431-3441, 2003.
35. Naor D, Wallach-Dayan SB, Zahalka MA, et al: Involvement of CD44, a molecule with a thousand faces, in cancer dissemination. Semin Cancer Biol 18: 260-267, 2008.
36. Domenzain C, Docampo MJ, Miquel-Serra L, et al: Differential expression of versican isoforms is a component of the human melanoma cell differentiation process. Biochim Biophys Acta 1642: 107-114, 2003.
37. Zizola CF, Julianelli V, Bertolesi G, et al: Role of versican and hyaluronan in the differentiation of 3T3-L1 cells into preadipocytes and mature adipocytes. Matrix Biol 26: 419-430, 2007.
38. Sheng W, Wang G, Wang Y, et al: The roles of versican V1 and V2 isoforms in cell proliferation and apoptosis. Mol Biol Cell 16: 1330-1340, 2005. (Pubitemid 40349568)
39. Ponta H, Sherman L and Herrlich PA: CD44: from adhesion molecules to signalling regulators. Nat Rev Mol Cell Biol 4: 33-45, 2003.
40. Subramaniam V, Vincent IR, Gilakjan M, et al: Suppression of human colon cancer tumors in nude mice by siRNA CD44 gene therapy. Exp Mol Pathol 83: 332-340, 2007.
41. Xie Z, Choong PF, Poon LF, et al: Inhibition of CD44 expression in hepatocellular carcinoma cells enhances apoptosis, chemosensitivity, and reduces tumorigenesis and invasion. Cancer Chemother Pharmacol 62: 949-957, 2008.
42. Hall A: The cytoskeleton and cancer. Cancer Metastasis Rev 28: 5-14, 2009.
43. Bourguignon LY: Hyaluronan-mediated CD44 activation of RhoGTPase signaling and cytoskeleton function promotes tumor progression. Semin Cancer Biol 18: 251-259, 2008.
44. Lee JL, Wang MJ, Sudhir PR, et al: CD44 engagement promotes matrix-derived survival through the CD44-SRC-integrin axis in lipid rafts. Mol Cell Biol 28: 5710-5723, 2008.
45. Thankamony SP and Knudson W: Acylation of CD44 and its association with lipid rafts are required for receptor and hyaluronan endocytosis. J Biol Chem 281: 34601-34609, 2006.
46. Hua Q, Knudson CB and Knudson W: Internalization of hyaluronan by chondrocytes occurs via receptor-mediated endocytosis. J Cell Sci 106: 365-375, 1993. (Pubitemid 23286807)